Sequence, structure, function, immunity: structural genomics of costimulation

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Immunological Reviews

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1600-065X.2009.00778.xPMID 19426233PMCID PMC3001128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells

  2009cited by this paper
• T‐cell receptor binding affinities and kinetics: impact on T‐cell activity and specificity

  2009cited by this paper
• Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2

  2008cited by this paper
• The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors

  2008cited by this paper
• Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice.

  2008cited by this paper
• New roles for TIM family members in immune regulation

  2008cited by this paper
• Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

  2008cited by this paper
• The inhibitory collagen receptor LAIR‐1 (CD305)

  2008cited by this paper
• The SLAM and SAP gene families control innate and adaptive immune responses.

  2008cited by this paper
• Structural basis for ligand-mediated mouse GITR activation

  2008cited by this paper
• Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

  2008cited by this paper
• The Soluble Leukocyte-Associated Ig-Like Receptor (LAIR)-2 Antagonizes the Collagen/LAIR-1 Inhibitory Immune Interaction1

  2008cited by this paper
• Takai Y, Miyoshi J, Ikeda W, Ogita H.. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 9: 603-615

  2008cited by this paper
• Identification of transient hub proteins and the possible structural basis for their multiple interactions

  2008cited by this paper
• The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.

  2008cited by this paper
• Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states

  2008cited by this paper
• An empirical framework for binary interactome mapping

  2008cited by this paper
• Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation

  2008cited by this paper
• The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum

  2008cited by this paper
• Evolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily

  2008cited by this paper
• Epitope-Dependent Effect of Anti-Murine TIM-1 Monoclonal Antibodies on T Cell Activity and Lung Immune Responses

  2007influential reference
• Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

  2007cited by this paper
• Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds.

  2007cited by this paper
• Structure of CD84 provides insight into SLAM family function

  2007influential reference
• Structural genomics of protein phosphatases

  2007cited by this paper
• Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family.

  2007cited by this paper
• Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function

  2007influential reference
• Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

  2007cited by this paper
• Identification of Tim4 as a phosphatidylserine receptor

  2007cited by this paper
• Cancer immunoediting by GITR (glucocorticoid‐induced TNF‐related protein) ligand in humans: NK cell/tumor cell interactions

  2007cited by this paper
• Regulated expression of the inhibitory receptor LAIR‐1 on human peripheral T cells during T cell activation and differentiation

  2007cited by this paper
• Structures of T Cell Immunoglobulin Mucin Receptors 1 and 2 Reveal Mechanisms for Regulation of Immune Responses by the TIM Receptor Family

  2007cited by this paper
• The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

  2007cited by this paper
• Mouse leukocyte-associated Ig-like receptor-1 (mLAIR-1) functions as an inhibitory collagen-binding receptor on immune cells.

  2007cited by this paper
• T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface.

  2007cited by this paper
• Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family.

  2007influential reference
• GITR/GITRL: More than an effector T cell co‐stimulatory system

  2007cited by this paper
• TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

  2007cited by this paper
• Crystal Structure of the V Domain of Human Nectin-like Molecule-1/Syncam3/Tsll1/Igsf4b, a Neural Tissue-specific Immunoglobulin-like Cell-Cell Adhesion Molecule*

  2006cited by this paper
• Restoring function in exhausted CD8 T cells during chronic viral infection

  2006cited by this paper
• A molecular perspective of CTLA-4 function.

  2006cited by this paper
• Regulation of B Cell Tolerance by the Lupus Susceptibility Gene Ly108

  2006cited by this paper
• NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family.

  2006cited by this paper
• The crystal structure of the costimulatory OX40-OX40L complex.

  2006influential reference
• The PD-1-PD-L pathway in immunological tolerance.

  2006cited by this paper
• PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

  2006cited by this paper
• Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1

  2006cited by this paper
• The GITR–GITRL interaction: co-stimulation or contrasuppression of regulatory activity?

  2006cited by this paper
• Immune regulation by SLAM family receptors and SAP-related adaptors

  2006cited by this paper
• Interactions of Tumor Necrosis Factor (TNF) and TNF Receptor Family Members in the Mouse and Human*

  2006cited by this paper
• Structural Basis of Inducible Costimulator Ligand Costimulatory Function: Determination of the Cell Surface Oligomeric State and Functional Mapping of the Receptor Binding Site of the Protein1

  2006cited by this paper
• Towards a proteome-scale map of the human protein–protein interaction network

  2005cited by this paper
• TNF/TNFR family members in costimulation of T cell responses.

  2005cited by this paper
• The B7 family revisited.

  2005cited by this paper
• TIM-4 is the ligand for TIM-1, and the TIM-1–TIM-4 interaction regulates T cell proliferation

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• TIM-1 induces T cell activation and inhibits the development of peripheral tolerance

  2005cited by this paper
• T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand

  2005cited by this paper
• A human protein-protein interaction network: a resource for annotating the proteome.

  2005cited by this paper
• Shotgun Crystallization Strategy for Structural Genomics II: Crystallization Conditions that Produce High Resolution Structures for T. maritima Proteins

  2005cited by this paper
• CD229 (Ly9) Lymphocyte Cell Surface Receptor Interacts Homophilically through Its N-Terminal Domain and Relocalizes to the Immunological Synapse 1

  2005cited by this paper
• The TIM gene family regulates autoimmune and allergic diseases.

  2005cited by this paper
• TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis

  2005influential reference
• GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily

  2005cited by this paper
• Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn

  2005cited by this paper
• The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

  2005cited by this paper
• Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties

  2005cited by this paper
• Crystal structure of a soluble CD28-Fab complex

  2005influential reference
• Tim-2 regulates T helper type 2 responses and autoimmunity

  2005cited by this paper
• Different cell surface oligomeric states of B7-1 and B7-2: Implications for signaling

  2005cited by this paper
• Costimulation blockade with belatacept in renal transplantation.

  2005cited by this paper
• Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity

  2004cited by this paper
• Structural and functional analysis of the costimulatory receptor programmed death-1.

  2004cited by this paper
• Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus.

  2004cited by this paper
• The SAP family of adaptors in immune regulation.

  2004cited by this paper
• Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression 1

  2004cited by this paper
• Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells

  2004cited by this paper
• Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system.

  2004cited by this paper
• Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction1

  2004cited by this paper
• The soluble glucocorticoid-induced tumor necrosis factor receptor causes cell cycle arrest and apoptosis in murine macrophages.

  2004cited by this paper
• The dual-function CD150 receptor subfamily: the viral attraction

  2003cited by this paper
• The TIM gene family: emerging roles in immunity and disease

  2003cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• CD28-mediated co-stimulation: a quantitative support for TCR signalling

  2003cited by this paper
• Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

  2003cited by this paper
• Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

  2002cited by this paper
• Structural mechanisms of costimulation

  2002cited by this paper
• Leukocyte Ig-like receptor complex (LRC) in mice and men.

  2002influential reference
• CTLA-4–Ig regulates tryptophan catabolism in vivo

  2002cited by this paper
• The molecular architecture of the TNF superfamily.

  2002influential reference
• Human CD25+CD4+ T Suppressor Cell Clones Produce Transforming Growth Factor β, but not Interleukin 10, and Are Distinct from Type 1 T Regulatory Cells

  2002cited by this paper
• New regulatory co-receptors: inducible co-stimulator and PD-1.

  2002influential reference
• CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function.

  2002cited by this paper
• The B7–CD28 superfamily

  2002cited by this paper
• TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

  2002cited by this paper
• CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor.

  2002cited by this paper
• Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2

  2002influential reference
• The interaction properties of costimulatory molecules revisited.

  2002cited by this paper
• Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophage

  2002cited by this paper
• Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses

  2001influential reference

• On the same side: VISTA and its ligands interact in cis on the cell surface

  2025cites this paper
• Transitioning from native to synthetic receptors: broadening T-cell engineering and beyond

  2025cites this paper
• N-terminal ectodomain of BTNL2 inhibits T cell activation via a non-canonical interaction with its putative receptor that results in a delayed progression of DSS-induced ulcerative colitis.

  2024cites this paper
• On the same side: The immune regulatory protein Vista and its ligands interact in cis

  2024cites this paper
• Optimal selection of suitable templates in protein interface prediction

  2023cites this paper
• Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?

  2023cites this paper
• The interplay between membrane topology and mechanical forces in regulating T cell receptor activity

  2022cites this paper
• Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab.

  2022cites this paper
• Canine Morbillivirus from Colombian Lineage Exhibits In Silico and In Vitro Potential to Infect Human Cells

  2021cites this paper
• Clinical Experience with CTLA-4 Blockade for Cancer Immunotherapy: From the Monospecific Monoclonal Antibody Ipilimumab to Probodies and Bispecific Molecules Targeting The Tumor Microenvironment.

  2021cites this paper
• Multiple mechanisms for TRAF3-mediated regulation of the T cell costimulatory receptor GITR

  2021cites this paper
• Interacting Genetic Lesions of Melanoma in the Tumor Microenvironment: Defining a Viable Therapy.

  2021cites this paper
• Antibodies targeting enzyme inhibition as potential tools for research and drug development

  2021cites this paper
• A review of pharmacological and pharmacokinetic properties of Forsythiaside A.

  2021cites this paper
• Residue-based pharmacophore approaches to study protein-protein interactions.

  2021cites this paper
• Estimating the accuracy of pharmacophore‐based detection of cognate receptor‐ligand pairs in the immunoglobulin superfamily

  2021cites this paper
• Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines

  2020cites this paper
• How Does an Ectodomain of Membrane-Associated Proteins Stand Upright and Exert Robust Signal?

  2020cites this paper
• Discovery of receptor‐ligand interfaces in the immunoglobulin superfamily

  2020cites this paper
• T cell costimulation, checkpoint inhibitors and anti-tumor therapy

  2020cites this paper
• Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complex

  2020cites this paper
• Divergent Traits and Ligand-Binding Properties of the Cytomegalovirus CD48 Gene Family

  2020cites this paper
• Structural Insights into N-Terminal IgV Domain of BTNL2, a T Cell Inhibitory Molecule, Suggests a Non-canonical Binding Interface for its Putative Receptors.

  2020cites this paper
• Immunoglobulin-fold containing bacterial adhesins: Molecular and structural perspectives in host tissue colonization and infection.

  2020cites this paper
• How do extracellular membrane-associated proteins stand erect and signal?

  2020cites this paper
• Computational Redesign of PD-1 Interface for PD-L1 Ligand Selectivity.

  2019cites this paper
• Structural Basis of CD160:HVEM Recognition.

  2019cites this paper
• Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.

  2019cites this paper
• CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders.

  2019cites this paper
• IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer Immunotherapy

  2019cites this paper
• Crystal structure of human CD160 and HVEM complex

  2019cites this paper
• Crystal structure of m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon receptor binding

  2018influential citation
• The immunological synapse as a pharmacological target

  2018cites this paper
• A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.

  2018cites this paper
• Strategies to Address Chimeric Antigen Receptor Tonic Signaling

  2018cites this paper
• Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding

  2018influential citation
• Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier

  2018influential citation
• Targeting IgV-like Domain Immune Checkpoint Receptors with Novel Nucleic Acid and Protein-Based Therapeutics

  2018cites this paper
• Glucocorticoid-induced TNFR-related gene (GITR) as a therapeutic target for immunotherapy

  2018cites this paper
• The “Phagocytic Synapse” and Clearance of Apoptotic Cells

  2017cites this paper
• Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling

  2017cites this paper
• Modulating T Cell costimulation to prevent renal allograft rejection in nonhuman primates

  2017cites this paper
• GITR: A Modulator of Regulatory and Effector T‐Cell Activity, Crucial in Tumour Rejection and Autoimmune Diseases

  2017cites this paper
• Structural, mutational and biophysical studies reveal a canonical mode of molecular recognition between immune receptor TIGIT and nectin‐2

  2017cites this paper
• Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy

  2017cites this paper
• RCSB Protein Data Bank: Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical education

  2017cites this paper
• Forsythoside A Inhibits BVDV Replication via TRAF2-Dependent CD28–4-1BB Signaling in Bovine PBMCs

  2016cites this paper
• Co-stimulate or Co-inhibit Regulatory T Cells, Which Side to Go?

  2016influential citation
• Modulation of tumor immunity: a patent evaluation of WO2015026684A1

  2016cites this paper
• BioCatNet: A Database System for the Integration of Enzyme Sequences and Biocatalytic Experiments

  2016cites this paper
• Ley Protective Autoimmunity in Atherosclerosis 431

  2016cites this paper
• Generating Peripheral Blood Derived Lymphocytes Reacting Against Autologous Primary AML Blasts

  2016cites this paper
• Unravelling the mechanisms for mucosal tolerance induction using the CTA 1 R 7 KX-DD immunomodulating fusion protein Effective treatment options for autoimmune diseases

  2016cites this paper
• 2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in Atherosclerosis

  2016cites this paper
• Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format

  2016cites this paper
• Costimulation Immunotherapy in Infectious Diseases

  2015cites this paper
• The pharmacology of second-generation chimeric antigen receptors

  2015cites this paper
• Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren's syndrome?

  2015cites this paper
• Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy

  2015influential citation
• The T Cell Co-stimulatory Molecule GITR in the Control and Treatment of a Persistent Viral Infection

  2015influential citation
• B Cell Central Tolerance: Controlling Self-Reactive B Cells in the Bone Marrow

  2014cites this paper
• Caractérisation des lymphocytes T CD8+ spécifiques du VIH chez les « HIV controllers »

  2014influential citation
• Considerations for Combined Immune Checkpoint Modulation and Radiation Treatment

  2014cites this paper
• Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies

  2014cites this paper
• Role of SLAM family receptors and specific adapter SAP in innate-like lymphocytes.

  2014cites this paper
• Cell-specific and context-dependent effects of GITR in cancer, autoimmunity, and infection.

  2014cites this paper
• Monoclonal Antibodies to CTLA-4 with Focus on Ipilimumab

  2014influential citation
• Molecular mechanisms of T cell co-stimulation and co-inhibition

  2013cites this paper
• The Interaction Between Allelic Variants of CD86 and CD40LG: A Common Risk Factor of Allergic Asthma and Rheumatoid Arthritis

  2013cites this paper
• Functional classification of immune regulatory proteins.

  2013influential citation
• Evaluating combinations of costimulatory antibody–ligand fusion proteins for targeted cancer immunotherapy

  2013cites this paper
• Enhanced antitumor activity mediated by human 4‐1BB‐engineered T cells

  2013cites this paper
• Immunoglobulin domains in Escherichia coli and other enterobacteria: from pathogenesis to applications in antibody technologies.

  2013influential citation
• Microsoft Word-26264595-file00.docx

  2013cites this paper
• Structure and T cell inhibition properties of B7 family member, B7-H3.

  2013cites this paper
• La molécula CD28 y su función en la activación de células T

  2013cites this paper
• Protein production from the structural genomics perspective: achievements and future needs.

  2013cites this paper
• Molecular mechanisms of T cell co-stimulation and co-inhibition

  2013cites this paper
• Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Ligand Triggering Upregulates Vascular Cell Adhesion Molecule-1 and Intercellular Adhesion Molecule-1 and Promotes Leukocyte Adhesion

  2013cites this paper
• Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer.

  2012cites this paper
• Pharmacological modulation of GITRL/GITR system: therapeutic perspectives

  2012cites this paper
• CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells

  2012cites this paper
• Cell Costimulation and Coinhibition : Genetics and Disease

  2011cites this paper
• Decoy strategies: the structure of TL1A:DcR3 complex.

  2011cites this paper
• Generation and evaluation of mammalian secreted and membrane protein expression libraries for high-throughput target discovery.

  2011cites this paper
• T‐cell intrinsic effects of GITR and 4‐1BB during viral infection and cancer immunotherapy

  2011influential citation
• Asthma translational medicine: report card.

  2011cites this paper
• Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.

  2011cites this paper
• Current methods in structural proteomics and its applications in biological sciences

  2011cites this paper
• T cell costimulation and coinhibition: genetics and disease.

  2011cites this paper
• The role of costimulatory pathways during the activation of human T cells

  2011influential citation
• New B-cell CD molecules.

  2011cites this paper
• The structure of TL1A-DCR3 COMPLEX

  2011cites this paper
• Receptors and ligands implicated in human T cell costimulatory processes.

  2010cites this paper
• T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells

  2010cites this paper
• Mechanisms of costimulation

  2009cites this paper
• The Cambridge Medical School: Department of Biochemistry

  2009cites this paper
• Obstructive sleep apnoea and its cardiovascular consequences.

  2009cites this paper
• structure of m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon receptor binding.

  year unknowncites this paper
• eview pilimumab : A novel immunostimulatory monoclonal antibody or the treatment of cancer

  year unknowncites this paper